RxDoctor Payments Data

Taryn Gallo, MD

Obstetrics & Gynecology · Sebastian, FLNPI 1922256494

Payments from drug & device makers

$841in general payments, 2019–2025

Across 26 payments — averaging $32.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Hologic Sales And Service, LLC$197
  • Astellas Pharma US Inc$116
  • Intuitive Surgical$113
  • Sumitomo Pharma America, Inc.$93
  • Medtronic$92
  • Cook Medical LLC$50
  • plus $180 from 10 others

What the payments were for

  • Food & beverage$73087%
  • Education$11113%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$841 in reported general payments places this provider in the 45th percentile of 2,438 obstetrics & gynecology providers in Florida.

See all obstetrics & gynecology providers in Florida

Medicare billing

Part B allowed, 2024
$72,712
Medicare patients
507
Services billed
844

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Estradiol297$21,377
PremarinEstrogens, Conjugated23$9,743
Estradiol (Once Weekly)Estradiol71$6,211
Estradiol (Twice Weekly)Estradiol33$4,554
ProgesteroneProgesterone, Micronized103$3,315
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip148$3,054
Clobetasol Propionate67$2,184
ValacyclovirValacyclovir Hcl63$2,059
Medroxyprogesterone Acetate33$904
Betamethasone Valerate16$408
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst25$405
Metronidazole15$331
Alendronate Sodium29$331
Fluconazole35$294
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim12$27

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerPremarin$18$9,74323 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 2,438 obstetrics & gynecology providers in Florida.

Other obstetrics & gynecology in Sebastian

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →